These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27173875)

  • 41. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
    Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
    Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
    Dimberg J; Hugander A; Löfgren S; Wågsäter D
    Int J Mol Med; 2007 Jan; 19(1):11-5. PubMed ID: 17143542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.
    de Oliveira KB; Guembarovski RL; Guembarovski AM; da Silva do Amaral Herrera AC; Sobrinho WJ; Ariza CB; Watanabe MA
    Clin Exp Med; 2013 Aug; 13(3):211-9. PubMed ID: 22699677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia.
    Lyu M; Li Y; Hao Y; Sun T; Liu W; Lyu C; Fu R; Li H; Xue F; Liu X; Zhang L; Yang R
    Platelets; 2016 Jun; 27(4):338-43. PubMed ID: 26587874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.
    Binsky I; Lantner F; Grabovsky V; Harpaz N; Shvidel L; Berrebi A; Goldenberg DM; Leng L; Bucala R; Alon R; Haran M; Shachar I
    J Immunol; 2010 May; 184(9):4761-9. PubMed ID: 20357260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients.
    Aladle DAAM; Ghannam MA; El-Ashwah S; Ghobrial FEI; Mortada MI
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1035-1043. PubMed ID: 33906294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
    Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
    Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
    Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
    Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
    Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
    Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
    Khalid S; Hanif R
    PeerJ; 2017; 5():e3822. PubMed ID: 28929029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.
    Tinhofer I; Rubenzer G; Holler C; Hofstaetter E; Stoecher M; Egle A; Steurer M; Greil R
    Blood; 2006 Nov; 108(9):2950-6. PubMed ID: 16825496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.
    Ganghammer S; Gutjahr J; Hutterer E; Krenn PW; Pucher S; Zelle-Rieser C; Jöhrer K; Wijtmans M; Leurs R; Smit MJ; Gattei V; Greil R; Hartmann TN
    Haematologica; 2016 Mar; 101(3):e99-102. PubMed ID: 26589908
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multidrug resistance in chronic lymphocytic leukemia].
    Szendrei T; Magyarlaki T; Kovács G; Nagy A; Szomor A; Molnár L; Dávid M; Tokés-Füzesi M; Rideg O; Pótó L; Pajor L; Kajtár B; Losonczy H
    Orv Hetil; 2008 Jan; 149(4):161-7. PubMed ID: 18201958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.
    Cai C; Wang LH; Dong Q; Wu ZJ; Li MY; Sun YH
    Tissue Antigens; 2013 Sep; 82(3):165-70. PubMed ID: 24032722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.